mesothelioma

Esophageal Stents As a Palliative Care Measure for Mesothelioma

Mesothelioma, a cancer that invades the wall lining of the lungs and other internal organs, is a particularly difficult type of cancer to treat. Almost universally related to the inhalation of asbestos particles, treatment of advanced stages of the disease is largely palliative. Palliative health care refers to the focus of relieving symptoms and pain […]

Esophageal Stents As a Palliative Care Measure for Mesothelioma Read More »

Data Supports Further Investigation of Mesothelioma Virotherapy

Oncolytics Biotech presented data that indicates malignant mesothelioma cells are sensitive to certain viruses. Their presentation titled “Combination Immunotherapy and Oncolytics Virotherapy for the Treatment of Malignant Mesothelioma” discussed in vitro data showing mesothelioma cells could be suitable targets for reoviruses which could then attack and compromise them. The company currently has 7 ongoing phase

Data Supports Further Investigation of Mesothelioma Virotherapy Read More »

Piroxicam and Cisplatin Show Promise Against Mesothelioma Cells

Piroxicam, a nonsteroidal anti-inflammatory drug (NSAID), has shown anti-tumoral activity which is amplified when combined with Cisplatin. Researchers used two mesothelioma cell lines and treated cells with piroxicam and cisplatin alone then combined the two treatments. Cell growth was significantly limited in both lines and treatment with either agent appeared to disrupt cell cycle phase

Piroxicam and Cisplatin Show Promise Against Mesothelioma Cells Read More »

Tour de Force presentation of evidence against asbestos companies

In article (opinion piece) out of The Herald (Scotland). Writer Joan McAlpine lays out the case for mesothelioma patients: the fact that asbestos companies knew of the hazards and continued to produce this hazardous material. “Mesothelioma sufferers already know what is killing them: exposure to asbestos dust. So they know who is to blame: irresponsible

Tour de Force presentation of evidence against asbestos companies Read More »